Biogaia AB ADR (BIOGY)

BioGaia AB ADR is a depositary receipt listed on OTC Markets that reflects the common stock of BioGaia AB (publ), a Sweden-based healthcare company incorporated in 1990 and headquartered in Stockholm. Through its ADR structure, the listed security represents exposure to the issuer’s ordinary shares rather than a separate operating business. BioGaia develops, manufactures, markets, and sells probiotic products aimed at gut, oral, and immune health across Europe, the Middle East, Africa, the United States, the Asia-Pacific region, Australia, and New Zealand. Its operations are organized into Pediatrics, Adult Health, and Other segments. The Pediatrics segment includes drops, oral rehydration solutions, gut health tablets, and cultures used in infant and milk formula, while Adult Health covers gut health tablets, bone health tablets, oral health lozenges, and related cultures. The Other segment includes packaging solutions, and sales are made through distribution partners and direct channels.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.